CEACAM1 is a Novel Culture-compatible Surface Marker of Expanded Long-term Reconstituting Hematopoietic Stem Cells
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Gress V, Roussy M, Boulianne L, Bilodeau M, Cardin S, El-Hachem N Blood Adv. 2023; 8(1):112-129.
PMID: 37729615 PMC: 10787250. DOI: 10.1182/bloodadvances.2022008899.
Safaee Talkhoncheh M, Baudet A, Ek F, Subramaniam A, Kao Y, Miharada N Blood Adv. 2023; 7(24):7407-7417.
PMID: 37487020 PMC: 10758717. DOI: 10.1182/bloodadvances.2023009844.
References
1.
Barker J
. Umbilical Cord Blood (UCB) transplantation: an alternative to the use of unrelated volunteer donors?. Hematology Am Soc Hematol Educ Program. 2007; :55-61.
DOI: 10.1182/asheducation-2007.1.55.
View
2.
Gray-Owen S, Blumberg R
. CEACAM1: contact-dependent control of immunity. Nat Rev Immunol. 2006; 6(6):433-46.
DOI: 10.1038/nri1864.
View
3.
Fares I, Chagraoui J, Gareau Y, Gingras S, Ruel R, Mayotte N
. Cord blood expansion. Pyrimidoindole derivatives are agonists of human hematopoietic stem cell self-renewal. Science. 2014; 345(6203):1509-12.
PMC: 4372335.
DOI: 10.1126/science.1256337.
View
4.
Yin A, Miraglia S, Zanjani E, Almeida-Porada G, Ogawa M, Leary A
. AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood. 1998; 90(12):5002-12.
View
5.
Dever D, Porteus M
. The changing landscape of gene editing in hematopoietic stem cells: a step towards Cas9 clinical translation. Curr Opin Hematol. 2017; 24(6):481-488.
PMC: 5766279.
DOI: 10.1097/MOH.0000000000000385.
View